Fmoc-L-tert-leucine

CAS: 132684-60-7

Ref. 3D-FF43211

Produktinformation

• Name: Fmoc-L-tert-leucine
• Synonyme: Fmoc-L-Tle-OH, Fmoc-tBu-Gly-OH, Fmoc-Tle-OH, NALPHA-9-Fluorenylmethoxycarbonyl-L-tert-leucine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-3-methyl-L-valine

Beschreibung

Fmoc-L-tert-leucine is an amide that is used for the treatment of prostate cancer. Fmoc-L-tert-leucine has been shown to be effective in treating resistant prostate cancer cells in vivo, and it has been shown to inhibit the growth of prostate cancer cells in vitro. This drug also has a diagnostic effect on prostate cancer cells. The uptake of this drug by prostate cancer cells is dependent on the presence of caspase-9, which may be due to its ability to inhibit apoptosis.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 353.41 g/mol
• Formel: C₂₁H₂₃NO₄
• Reinheit: Min. 95%
• Farbe/Form: White Powder
• InChl: InChI=1S/C21H23NO4/c1-21(2,3)18(19(23)24)22-20(25)26-12-17-15-10-6-4-8-13(15)14-9-5-7-11-16(14)17/h4-11,17-18H,12H2,1-3H3,(H,22,25)(H,23,24)/t18-/m1/s1
• InChI Key: InChIKey=VZOHGJIGTNUNNC-GOSISDBHSA-N
• SMILES: CC(C)(C)[C@H](NC(=O)OCC1c2ccccc2-c2ccccc21)C(=O)O